FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890949684> ?p ?o ?g. }

• W2890949684 abstract "Accumulating evidence suggests that cancer stem cells (CSCs) play a critical role in tumor initiation, progression and therapy, and recent studies have indicated that Forkhead box C1 (FOXC1) is strongly associated with CSCs. This study investigates the regulatory effects of FOXC1 on CSC-like properties in non-small cell lung cancer (NSCLC).We analyzed FOXC1 expression in NSCLC using the Cancer Genome Atlas (TCGA) database on UALCANC and performed survival analyses of NSCLC patients on Human Protein Atlas. CSC-like properties were analyzed based on CSC marker-positive cell population, self-renewal ability, stemness-related gene expression, tumorigenicity and drug resistance. The percentage of CD133+ cells was analyzed by flow cytometric analysis. Self-renewal ability was detected by sphere-formation analysis. Real-time PCR, western blotting and immunohistochemical staining were employed to detect mRNA and protein levels. Tumorigenicity was determined based on a xenograft formation assay, and effects of FOXC1 on drug resistance were assessed by cell viability and apoptosis assays. Luciferase reporter and chromatin immunoprecipitation (ChIP) assays were used to investigate the binding of FOXC1 to beta-catenin promoter.FOXC1 expression was found to be elevated in NSCLC tissues and negatively correlated with patient survival. FOXC1 knockdown reduced CD133+ cell percentage, suppressed self-renewal ability, decreased expression of stemness-related genes (Oct4, NANOG, SOX2 and ABCG2) and inhibited NSCLC cell tumorigenicity in vivo. Moreover, FOXC1 knockdown increased cisplatin and docetaxel sensitivity and reduced gefitinib resistance, whereas FOXC1 overexpression enhanced CSC-like properties. Luciferase reporter and ChIP assays showed beta-catenin to be a direct transcriptional target of FOXC1. Furthermore, overexpression of beta-catenin reversed the CSC-like property inhibition induced by FOXC1 knockdown, and knockdown of beta-catenin attenuated the CSC-like properties induced by FOXC1 overexpression.This study demonstrates that FOXC1 induces CSC-like properties in NSCLC by promoting beta-catenin expression. The findings indicate that FOXC1 is a potential molecular target for anti-CSC-based therapies in NSCLC." @default.
• W2890949684 created "2018-09-27" @default.
• W2890949684 creator A5011090841 @default.
• W2890949684 creator A5021471823 @default.
• W2890949684 creator A5023137812 @default.
• W2890949684 creator A5046001403 @default.
• W2890949684 creator A5054193841 @default.
• W2890949684 creator A5059904093 @default.
• W2890949684 creator A5070983459 @default.
• W2890949684 date "2018-09-06" @default.
• W2890949684 modified "2023-10-16" @default.
• W2890949684 title "FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC" @default.
• W2890949684 cites W1524354116 @default.
• W2890949684 cites W1563722698 @default.
• W2890949684 cites W1982225414 @default.
• W2890949684 cites W1983357205 @default.
• W2890949684 cites W1986553481 @default.
• W2890949684 cites W1990013637 @default.
• W2890949684 cites W1993070704 @default.
• W2890949684 cites W1993749140 @default.
• W2890949684 cites W1994552886 @default.
• W2890949684 cites W1994599132 @default.
• W2890949684 cites W1996405564 @default.
• W2890949684 cites W2015814158 @default.
• W2890949684 cites W2019615042 @default.
• W2890949684 cites W2020458598 @default.
• W2890949684 cites W2021349501 @default.
• W2890949684 cites W2022881840 @default.
• W2890949684 cites W2039109621 @default.
• W2890949684 cites W2047314469 @default.
• W2890949684 cites W2050556924 @default.
• W2890949684 cites W2068416436 @default.
• W2890949684 cites W2070241543 @default.
• W2890949684 cites W2071628605 @default.
• W2890949684 cites W2086340756 @default.
• W2890949684 cites W2097213648 @default.
• W2890949684 cites W2102085111 @default.
• W2890949684 cites W2113002082 @default.
• W2890949684 cites W2127438438 @default.
• W2890949684 cites W2148790937 @default.
• W2890949684 cites W2152558791 @default.
• W2890949684 cites W2168854899 @default.
• W2890949684 cites W2256043817 @default.
• W2890949684 cites W2259656061 @default.
• W2890949684 cites W2266703738 @default.
• W2890949684 cites W2268952684 @default.
• W2890949684 cites W2278137857 @default.
• W2890949684 cites W2290767614 @default.
• W2890949684 cites W2299454500 @default.
• W2890949684 cites W2337875469 @default.
• W2890949684 cites W2343414074 @default.
• W2890949684 cites W2508069933 @default.
• W2890949684 cites W2521112078 @default.
• W2890949684 cites W2537192996 @default.
• W2890949684 cites W2592213010 @default.
• W2890949684 cites W2597318557 @default.
• W2890949684 cites W2736730167 @default.
• W2890949684 cites W2738166999 @default.
• W2890949684 cites W2743225886 @default.
• W2890949684 cites W2749235803 @default.
• W2890949684 cites W2763367287 @default.
• W2890949684 cites W2765831845 @default.
• W2890949684 cites W2768800571 @default.
• W2890949684 cites W2769400169 @default.
• W2890949684 cites W2771110788 @default.
• W2890949684 cites W2791902074 @default.
• W2890949684 cites W2794409408 @default.
• W2890949684 cites W2800566434 @default.
• W2890949684 cites W2917837889 @default.
• W2890949684 doi "https://doi.org/10.1186/s13046-018-0894-0" @default.
• W2890949684 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6127900" @default.
• W2890949684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30189871" @default.
• W2890949684 hasPublicationYear "2018" @default.
• W2890949684 type Work @default.
• W2890949684 sameAs 2890949684 @default.
• W2890949684 citedByCount "60" @default.
• W2890949684 countsByYear W28909496842018 @default.
• W2890949684 countsByYear W28909496842019 @default.
• W2890949684 countsByYear W28909496842020 @default.
• W2890949684 countsByYear W28909496842021 @default.
• W2890949684 countsByYear W28909496842022 @default.
• W2890949684 countsByYear W28909496842023 @default.
• W2890949684 crossrefType "journal-article" @default.
• W2890949684 hasAuthorship W2890949684A5011090841 @default.
• W2890949684 hasAuthorship W2890949684A5021471823 @default.
• W2890949684 hasAuthorship W2890949684A5023137812 @default.
• W2890949684 hasAuthorship W2890949684A5046001403 @default.
• W2890949684 hasAuthorship W2890949684A5054193841 @default.
• W2890949684 hasAuthorship W2890949684A5059904093 @default.
• W2890949684 hasAuthorship W2890949684A5070983459 @default.
• W2890949684 hasBestOaLocation W28909496841 @default.
• W2890949684 hasConcept C101762097 @default.
• W2890949684 hasConcept C104317684 @default.
• W2890949684 hasConcept C107459253 @default.
• W2890949684 hasConcept C121608353 @default.
• W2890949684 hasConcept C134320426 @default.
• W2890949684 hasConcept C136302470 @default.
• W2890949684 hasConcept C145103041 @default.
• W2890949684 hasConcept C1491633281 @default.
• W2890949684 hasConcept C150194340 @default.

• next